Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,607 | -69,776 | -123,462 | -106,482 | -95,402 |
| Depreciation Amortization | 373 | 925 | 1,221 | 1,199 | 1,330 |
| Other Working Capital | 4,276 | -11,199 | 4,680 | 287 | 7,427 |
| Other Operating Activity | 6,754 | 8,114 | 13,546 | 14,576 | 24,431 |
| Operating Cash Flow | $-48,204 | $-71,936 | $-104,015 | $-90,420 | $-62,214 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -98 | -265 | -924 |
| Investing Cash Flow | $N/A | $N/A | $-98 | $-265 | $-924 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,125 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 100 | 9,557 | 336 | 61,971 | 71,423 |
| Common Stock Repurchased | -897 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -52 | -46 | -259 | -758 | -1,911 |
| Financing Cash Flow | $6,276 | $9,511 | $77 | $61,213 | $69,512 |
| Beginning Cash Position | 49,046 | 111,471 | 215,507 | 244,979 | 238,605 |
| End Cash Position | 7,118 | 49,046 | 111,471 | 215,507 | 244,979 |
| Net Cash Flow | $-41,928 | $-62,425 | $-104,036 | $-29,472 | $6,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,204 | -71,936 | -104,015 | -90,420 | -62,214 |
| Capital Expenditure | N/A | N/A | -98 | -268 | -924 |
| Free Cash Flow | -48,204 | -71,936 | -104,113 | -90,688 | -63,138 |